CIK 0000885590
- Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- Phone
- +1 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $258,894
- in 1 filing, $259K under 10b5-1 plans
Net −$258,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-03 | APPIO THOMAS Chief Executive Officer | Shares withheld for taxes | −4,348 | $9.16 | $40K | 983,478 |
| 2023-03-03 | APPIO THOMAS Chief Executive Officer | Shares withheld for taxes | −2,357 | $9.16 | $22K | 981,121 |
| 2023-03-02 | APPIO THOMAS Chief Executive Officer | Shares withheld for taxes | −17,432 | $9.25 | $161K | 468,141 |
| 2023-03-02 | APPIO THOMAS Chief Executive Officer | Grant or award | +523,155 | 991,296 | ||
| 2023-02-27 | APPIO THOMAS Chief Executive Officer | Shares withheld for taxes | −4,258 | $9.57 | $41K | 487,642 |
| 2023-02-27 | APPIO THOMAS Chief Executive Officer | Shares withheld for taxes | −2,069 | $9.57 | $20K | 485,573 |
| 2022-09-01 | APPIO THOMAS Chief Executive Officer | Returned to the company | −15,389 | $6.59 | $101K | 491,900 |
| 2022-05-10 | APPIO THOMAS Chief Executive Officer | Option exercise | +12,447 | 487,714 | ||
| 2022-05-10 | APPIO THOMAS Chief Executive Officer | Option exercise | +19,575 | 507,289 | ||
| 2022-05-10 | APPIO THOMAS Chief Executive Officer | Grant or award · Restricted Share Units | +12,447 | 0 | ||
| 2022-05-10 | APPIO THOMAS Chief Executive Officer | Option exercise · Restricted Share Units | −12,447 | $9.40 | $117K | 0 |
| 2022-05-10 | APPIO THOMAS Chief Executive Officer | Grant or award · Restricted Share Units | +19,575 | 0 | ||
| 2022-05-10 | APPIO THOMAS Chief Executive Officer | Option exercise · Restricted Share Units | −19,575 | $9.40 | $184K | 0 |
| 2022-03-03 | APPIO THOMAS CEO, Pharma Business | Shares withheld for taxes | −5,564 | $23.61 | $131K | 475,267 |
| 2022-03-02 | APPIO THOMAS CEO, Pharma Business | Grant or award | +152,690 | 480,831 | ||
| 2022-03-02 | APPIO THOMAS CEO, Pharma Business | Grant or award · Non-Qualified Stock Options (right to purchase) | +565,330 | 565,330 | ||
| 2022-02-27 | APPIO THOMAS CEO, Pharma Business | Option exercise | +24,292 | 341,517 | ||
| 2022-02-27 | APPIO THOMAS CEO, Pharma Business | Shares withheld for taxes | −8,782 | $24.35 | $214K | 332,735 |
| 2022-02-27 | APPIO THOMAS CEO, Pharma Business | Shares withheld for taxes | −2,402 | $24.35 | $58K | 328,141 |
| 2022-02-27 | APPIO THOMAS CEO, Pharma Business | Grant or award · Restricted Share Units | +24,292 | 0 |
Page 2 of 4 · 64 trades